US Patent 7501122 Treatment with anti-ErbB2 antibody combinations
Patent 7501122 was granted and assigned to Genentech on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+131 characters)
Article
Patent abstract
The present application describes methods for treating ErbB-expressing cancer with anti-ErbB2 antibody combinations.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07501122 Treatment with anti-ErbB2 antibody combinations US Patent 7501122 Treatment with anti-ErbB2 antibody combinations
Infobox
Patent Number
0750112200
Patent Number
750112200
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075011220
Date of Patent
March 10, 2009
0Patent Application Number
112233610
Date Filed
September 9, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075011220
Date of Patent
March 10, 2009
0Patent Application Number
112233610
Date Filed
September 9, 2005
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07501122 Treatment with anti-ErbB2 antibody combinations
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07501122
Date of patent
March 10, 2009
Patent application number
11223361
Date Filed
September 9, 2005
Patent primary examiner
Find more entities like US Patent 7501122 Treatment with anti-ErbB2 antibody combinations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.